106 related articles for article (PubMed ID: 16950831)
1. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.
De Vry CG; Prasad S; Komuves L; Lorenzana C; Parham C; Le T; Adda S; Hoffman J; Kahoud N; Garlapati R; Shyamsundar R; Mai K; Zhang J; Muchamuel T; Dajee M; Schryver B; McEvoy LM; Ehrhardt RO
Gut; 2007 Apr; 56(4):524-33. PubMed ID: 16950831
[TBL] [Abstract][Full Text] [Related]
2. Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease.
Lloyd K; Papoutsopoulou S; Smith E; Stegmaier P; Bergey F; Morris L; Kittner M; England H; Spiller D; White MHR; Duckworth CA; Campbell BJ; Poroikov V; Martins Dos Santos VAP; Kel A; Muller W; Pritchard DM; Probert C; Burkitt MD;
Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 32958515
[TBL] [Abstract][Full Text] [Related]
3. Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease.
Verstockt B; Perrier C; De Hertogh G; Cremer J; Creyns B; Van Assche G; Ferrante M; Ceuppens JL; Vermeire S; Breynaert C
Front Immunol; 2018; 9():2983. PubMed ID: 30619339
[No Abstract] [Full Text] [Related]
4. Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease.
Date AA; Halpert G; Babu T; Ortiz J; Kanvinde P; Dimitrion P; Narayan J; Zierden H; Betageri K; Musmanno O; Wiegand H; Huang X; Gumber S; Hanes J; Ensign LM
Biomaterials; 2018 Dec; 185():97-105. PubMed ID: 30236840
[TBL] [Abstract][Full Text] [Related]
5. Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.
Gonzalez-Rey E; Varela N; Sheibanie AF; Chorny A; Ganea D; Delgado M
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4228-33. PubMed ID: 16537513
[TBL] [Abstract][Full Text] [Related]
6. An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasis.
Zhang X; Yuan Z; Wu J; He Y; Lu G; Zhang D; Zhao Y; Wu R; Lv Y; Cai K; He S
ACS Nano; 2023 Nov; 17(21):21116-21133. PubMed ID: 37843108
[TBL] [Abstract][Full Text] [Related]
7. A Thermo-Sensitive Delivery Platform for Topical Administration of Inflammatory Bowel Disease Therapies.
Sinha SR; Nguyen LP; Inayathullah M; Malkovskiy A; Habte F; Rajadas J; Habtezion A
Gastroenterology; 2015 Jul; 149(1):52-55.e2. PubMed ID: 25863215
[TBL] [Abstract][Full Text] [Related]
8. Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-β,
Smyth DJ; White MPJ; Johnston CJC; Donachie AM; Campillo Poveda M; McSorley HJ; Maizels RM
Discov Immunol; 2023; 2(1):kyad001. PubMed ID: 36855464
[TBL] [Abstract][Full Text] [Related]
9. The role of goblet cells in Crohn' s disease.
Wang Z; Shen J
Cell Biosci; 2024 Apr; 14(1):43. PubMed ID: 38561835
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection of mAb2G4/ODN/lip on Myocardial Ischemia-Reperfusion Injury via Inhibiting the NF-
Xu Z; Wei Z; Zhu Y; Jing G; Chen L; Zhan J; Wu Y
Cardiovasc Ther; 2023; 2023():5034683. PubMed ID: 37151220
[TBL] [Abstract][Full Text] [Related]
11. Development of a 32-gene signature using machine learning for accurate prediction of inflammatory bowel disease.
Yu S; Zhang M; Ye Z; Wang Y; Wang X; Chen YG
Cell Regen; 2023 Jan; 12(1):8. PubMed ID: 36600111
[TBL] [Abstract][Full Text] [Related]
12. Epithelial PBLD attenuates intestinal inflammatory response and improves intestinal barrier function by inhibiting NF-κB signaling.
Chen S; Liu H; Li Z; Tang J; Huang B; Zhi F; Zhao X
Cell Death Dis; 2021 May; 12(6):563. PubMed ID: 34059646
[TBL] [Abstract][Full Text] [Related]
13. Nuclear Factor κB (NF-κB)-Mediated Inflammation in Multiple Sclerosis.
Zhou Y; Cui C; Ma X; Luo W; Zheng SG; Qiu W
Front Immunol; 2020; 11():391. PubMed ID: 32265906
[TBL] [Abstract][Full Text] [Related]
14. Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis.
Nairz M; Haschka D; Dichtl S; Sonnweber T; Schroll A; Aßhoff M; Mindur JE; Moser PL; Wolf D; Swirski FK; Theurl I; Cerami A; Brines M; Weiss G
Sci Rep; 2017 Oct; 7(1):13012. PubMed ID: 29026145
[TBL] [Abstract][Full Text] [Related]
15. NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6.
Watanabe T; Asano N; Meng G; Yamashita K; Arai Y; Sakurai T; Kudo M; Fuss IJ; Kitani A; Shimosegawa T; Chiba T; Strober W
Mucosal Immunol; 2014 Nov; 7(6):1312-25. PubMed ID: 24670424
[TBL] [Abstract][Full Text] [Related]
16. Preventive Effect of TU-100 on a Type-2 Model of Colitis in Mice: Possible Involvement of Enhancing Adrenomedullin in Intestinal Epithelial Cells.
Kaneko A; Kono T; Miura N; Tsuchiya N; Yamamoto M
Gastroenterol Res Pract; 2013; 2013():384057. PubMed ID: 24348533
[TBL] [Abstract][Full Text] [Related]
17. The effect of melatonin on plasma markers of inflammation and on expression of nuclear factor-kappa beta in acetic acid-induced colitis in the rat.
Sayyed HG; Jaumdally RJ; Idriss NK; El Sers DA; Blann A
Dig Dis Sci; 2013 Nov; 58(11):3156-64. PubMed ID: 23925818
[TBL] [Abstract][Full Text] [Related]
18. Risk association between the NF-κB1 -94ins/delATTG promoter polymorphism and inflammatory bowel diseases: a meta-analysis.
Liang M; Xu X; Gong Y; Tang Y; Lin L
Dig Dis Sci; 2012 Sep; 57(9):2304-9. PubMed ID: 22828805
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of THSG on acetic acid-induced experimental colitis: involvement of upregulation of PPAR-γ and inhibition of the Nf-Κb inflammatory pathway.
Zeng C; Xiao JH; Chang MJ; Wang JL
Molecules; 2011 Oct; 16(10):8552-68. PubMed ID: 21993246
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel disease.
Andersen V; Christensen J; Ernst A; Jacobsen BA; Tjønneland A; Krarup HB; Vogel U
World J Gastroenterol; 2011 Jan; 17(2):197-206. PubMed ID: 21245992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
